Marc Machaalani, MD on MAdCAM-1 - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Marc Machaalani, MD on MAdCAM-1

Kidney cancer research at ESMO25: Dana-Farber's Marc Machaalani, MD, shares 3 key takeaways from his presentation on the protein MAdCAM-1 and its ability to predict outcomes in patients with metastatic renal cell carcinoma.

  • November 5, 2025

Share

Original Source(s)

Marc Machaalani, MD on MAdCAM-1

  • November 5, 2025

Related Content

Analyzing Prognostic and Immune Characteristics of Kidney Renal Clear Cell Carcinoma through Mitochondria-Associated Membranes and Identifying DNM1L as a Potential Target for Therapy Using Machine Learning Techniques

Multicenter Retrospective Analysis of Nivolumab Monotherapy Outcomes in Advanced Renal Cell Carcinoma by the Spanish Genitourinary Oncology Group

Evaluating the Prognostic Nutritional Index in Renal Cell Carcinoma Patients: A Comprehensive Systematic Review and Meta-Analysis Update